We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$259M
AUM Growth
-$6.37M
(-2.4%)
Cap. Flow
+$1.23M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
46.33%
Holding
70
New
3
Increased
26
Reduced
30
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Euronet Worldwide
EEFT
|
+$1.02M |
| 2 |
CELG
Celgene Corp
CELG
|
+$923K |
| 3 |
Meta Platforms (Facebook)
META
|
+$628K |
| 4 |
JPMorgan Chase
JPM
|
+$515K |
| 5 |
Cognizant
CTSH
|
+$433K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$1.18M |
| 2 |
Qualcomm
QCOM
|
+$507K |
| 3 |
AbbVie
ABBV
|
+$358K |
| 4 |
Automatic Data Processing
ADP
|
+$242K |
| 5 |
Apple
AAPL
|
+$226K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.75% |
| 2 | Technology | 19.6% |
| 3 | Consumer Staples | 12.07% |
| 4 | Communication Services | 10.08% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ExxonMobil
XOM
$644B
| $488K | 0.19% |
6,507
| – | – |
|
52
Core Laboratories
CLB
$488M
| $481K | 0.19% |
4,450
| – | – |
|
53
Constellation Brands
STZ
$22.2B
| $410K | 0.16% |
1,797
+305
| +20% | +$67.2K |
|
54
Cisco
CSCO
$457B
| $395K | 0.15% |
9,183
-1,950
| -18% | -$82.7K |
|
55
Honeywell
HON
$77B
| $390K | 0.15% |
2,978
+122
| +4% | +$16.9K |
|
56
Coca-Cola
KO
$377B
| $356K | 0.14% |
8,277
-2,600
| -24% | -$117K |
|
|
ESRX
57
DELISTED
Express Scripts Holding Company
ESRX
| $353K | 0.14% |
5,115
+100
| +2% | +$7.63K |
|
58
Eaton
ETN
$161B
| $336K | 0.13% |
4,206
| – | – |
|
59
AT&T
T
$159B
| $302K | 0.12% |
11,118
-1,661
| -13% | -$46.2K |
|
60
Bristol-Myers Squibb
BMY
$133B
| $300K | 0.12% |
4,755
-10
| -0.2% | -$643 |
|
61
Emerson Electric
EMR
$83.9B
| $276K | 0.11% |
4,057
| – | – |
|
62
CVS Health
CVS
$133B
| $258K | 0.1% |
4,160
-300
| -7% | -$21.5K |
|
63
IBM
IBM
$211B
| $241K | 0.09% |
1,647
-27
| -2% | -$4.08K |
|
64
Amazon
AMZN
$2.92T
| $221K | 0.09% |
+3,060
| New | +$219K |
|
65
Kraft Heinz
KHC
$30.7B
| $210K | 0.08% |
3,387
| – | – |
|
66
Target
TGT
$65.6B
| $202K | 0.08% |
+2,925
| New | +$213K |
|
67
Imunon
IMNN
$6.68M
| $24K | 0.01% |
+61
| New | +$29.3K |
|
|
GCVRZ
68
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $4K | ﹤0.01% |
10,260
| – | – |
|
69
DuPont de Nemours
DD
$18.5B
| – | – |
-1,227
| Closed | -$221K |
|
70
Wells Fargo
WFC
$261B
| – | – |
-3,475
| Closed | -$212K |
|
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Dillon & Associates held 70 positions worth $259M, down 2.4% from $265M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Dillon & Associates's Q1 2018 filing shows 3 new, 26 increased, 30 reduced and 2 closed positions. Its largest new stake was Amazon: 3,060 shares worth $221K. The largest sale was Enbridge, an estimated $1.18M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Staples.
- Dillon & Associates's largest Q1 2018 buy was Amazon: 3,060 shares worth $221K.
- Dillon & Associates added most to Euronet Worldwide in Q1 2018, an estimated $1.02M increase.
- Dillon & Associates's biggest Q1 2018 reduction was Enbridge, cutting an estimated $1.18M.
- Dillon & Associates fully exited DuPont de Nemours in Q1 2018, selling an estimated $221K.
- Dillon & Associates's ten largest holdings make up 46% of its $259M portfolio in Q1 2018.
- Dillon & Associates opened 3 new positions and closed 2 in Q1 2018.
- Dillon & Associates's portfolio value fell 2.4% quarter-over-quarter to $259M.
Based on Dillon & Associates's 13F filing for Q1 2018, filed 8 May 2018.